|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.315 USD | +1.09% |
|
-4.17% | +41.10% |
| 08/07 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 08/07 | Ovid Therapeutics Inc. Announces Executive Changes, Effective July 6, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 2.76 | 2.96 | 2.91 |
| Spread/Res. | -16.67% | -22.30% | -20.96% |
| Spread/Supp. | +2.22% | +14.43% | +25.00% |
| Support | 2.25 | 2.01 | 1.84 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OVID Stock
- Charts Ovid Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
